APR 10 (Otezla 10 mg)
Generic Name: apremilast
Pill with imprint APR 10 is Pink, Four-sided and has been identified as Otezla 10 mg. It is supplied by Celgene Corporation.
Otezla is used in the treatment of behcet's disease; psoriatic arthritis; plaque psoriasis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Otezla 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APR 10
Otezla
- Generic Name
- apremilast
- Imprint
- APR 10
- Strength
- 10 mg
- Color
- Pink
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
croscarmellose sodium,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59572-0630 | Celgene Corporation |
| 59572-0632 | Celgene Corporation |
Related images for "APR 10"
More about Otezla (apremilast)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (397)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: antirheumatics
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.